ENDOGENOUS DIGOXIN-LIKE IMMUNOREACTIVE SUBSTANCES ELIMINATED FROM SERUM SAMPLES FROM PATIENTS WITH LIVER-DISEASE BY THE EMIT COLUMN DIGOXIN ASSAY

被引:0
|
作者
KULAOTS, IA [1 ]
PUDEK, MR [1 ]
SECCOMBE, DW [1 ]
机构
[1] UNIV BRITISH COLUMBIA,VANCOUVER GEN HOSP,DEPT PATHOL,VANCOUVER V5Z 1M9,BC,CANADA
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:1490 / 1491
页数:2
相关论文
共 50 条
  • [31] DIGOXIN-LIKE IMMUNOREACTIVE SUBSTANCES IN KIDNEY-TRANSPLANT AND LIVER-TRANSPLANT PATIENTS
    DASGUPTA, A
    DENNEN, DA
    SALDANA, S
    CHOU, H
    MCLAWHON, RW
    CLINICAL CHEMISTRY, 1990, 36 (01) : 171 - 172
  • [32] ENDOGENOUS DIGOXIN-LIKE SUBSTANCES IN PREGNANCY - VALUE OF AN ASSAY-METHOD
    VAKSMANN, G
    BELHASSEN, A
    DHERBOMEZ, M
    PRESSE MEDICALE, 1987, 16 (20): : 1008 - 1008
  • [33] RADIOIMMUNOASSAY OF DIGOXIN IN SERUM USING MONOCLONAL-ANTIBODIES AND ASSESSMENT OF INTERFERENCE BY DIGOXIN-LIKE IMMUNOREACTIVE SUBSTANCES
    LOUCARIYIANNAKOU, E
    YIANNAKOU, L
    SOUVATZOGLOU, A
    DIAMANDIS, EP
    THERAPEUTIC DRUG MONITORING, 1990, 12 (02) : 195 - 200
  • [34] 2 NOVEL ENDOGENOUS DIGOXIN-LIKE IMMUNOREACTIVE SUBSTANCES ISOLATED FROM HUMAN-PLASMA ULTRAFILTRATE
    DASGUPTA, A
    YEO, KT
    MALIK, S
    SANDU, P
    AHMAD, S
    KENNY, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 148 (02) : 623 - 628
  • [35] INTERFERENCE FROM DIGOXIN-LIKE IMMUNOREACTIVE SUBSTANCE(S) IN COMMERCIAL DIGOXIN KIT ASSAY-METHODS
    MORRIS, RG
    FREWIN, DB
    SACCOIA, NC
    GOLDSWORTHY, WL
    JEFFRIES, WS
    MCPHEE, AJ
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 39 (04) : 359 - 363
  • [36] TREATMENT OF HUMAN SERUM WITH SULFOSALICYLIC ACID STRUCTURALLY ALTERS DIGOXIN AND ENDOGENOUS DIGOXIN-LIKE IMMUNOREACTIVE FACTOR
    QAZZAZ, HMAM
    GOUDY, S
    MILLER, JJ
    VALDES, R
    THERAPEUTIC DRUG MONITORING, 1995, 17 (01) : 53 - 59
  • [37] Suppression of total digoxin concentrations by digoxin-like immunoreactive substances in the MEIA digoxin assay - Elimination of negative interference by monitoring free digoxin concentrations
    Dasgupta, A
    Trejo, O
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1999, 111 (03) : 406 - 410
  • [38] Estimating concentrations of total digoxin and digoxin-like immunoreactive substances in volume-expanded patients being treated with digoxin
    Dasgupta, A
    Schammel, DP
    Limmany, AC
    Datta, P
    THERAPEUTIC DRUG MONITORING, 1996, 18 (01) : 34 - 39
  • [39] A PHYSICIANS OFFICE-BASED DIGOXIN ASSAY (SERALYZER) EVALUATED FOR INTERFERENCE BY ENDOGENOUS DIGOXIN-LIKE IMMUNOREACTIVE FACTORS
    MATHEKE, ML
    VALDES, R
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 1989, 19 (03): : 168 - 174
  • [40] ENDOGENOUS DIGOXIN-LIKE IMMUNOREACTIVE FACTORS (DLIF) AS MEASURED BY THE CEDIA(R) DIGOXIN ASSAY AND A FLUORESCENCE POLARIZATION IMMUNOASSAY
    SCHLEBUSCH, H
    JARAUSCH, J
    DOMKE, I
    WIENER KLINISCHE WOCHENSCHRIFT, 1992, 104 : 59 - 66